Identify Individuals with Diabetes Who Are at Greater Risk of Heart Disease and Stroke by Utilizing MyHap2™

The management of Diabetes patients specific to the morbidity and mortality associated with cardiovascular disease and stroke is a priority for health care providers.

• Haptoglobin is consistently associated as a marker in risk factor for cardiovascular disease.¹

• Studies have shown that patients suffering from diabetes with two copies of the haptoglobin 2 variant are at a 5 times greater risk of heart attack and stroke.¹

• MyHap2™ is a proprietary genetic test for Haptoglobin 1/2, People with a personal or family history of diabetes should be tested to evaluate their risk. 

• Order MyHap2™ to identify your diabetic patients with the highest risk of cardiovascular disease and stroke.